Acquired immunologic tolerance: With particular reference to transplantation

Immunologic Research

Volumn 38, Issue 1-3, 2007, Pages 6-41

  Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alloengraftment; Bone marrow transplantation; Chimerism; Clonal exhaustion deletion; Immune ignorance; Immunosuppression; Microchimerism; Organ transplantation; Tolerance

Indexed keywords

AZATHIOPRINE; PREDNISONE; TACROLIMUS;

ALLOENGRAFTMENT; ALLOGRAFT; BONE MARROW TRANSPLANTATION; CELL MIGRATION; CONFERENCE PAPER; ENGRAFTMENT; GRAFT REJECTION; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOCYTE ACTIVATION; LUNG TRANSPLANTATION; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

ANIMALS; BONE MARROW TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICE; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 33845936108     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-0001-7     Document Type: Conference Paper

References (110)

1. Billingham RE, Brent L, Medawar PB. "Actively acquired tolerance" of foreign cells. Nature 1953;172:603-6
2. Billingham R, Brent L, Medawar P. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos Trans R Soc Lond (Biol) 1956;239:357-412
3. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 1955;15:1023-9
4. Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963;117:385-95
5. Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, et al. Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 2004;77:926-9
6. Starzl TE, Lakkis FG. The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology 2006;43:S151-63
7. Starzl TE. The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg 2002;195:587-610
8. Takatsuki M, Uemoto SH, Inomata Y, Egawa H, Kiuchi T, Fujita S, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001;72:449-54
9. Starzl TE, Marchioro TL, Porter KA, Taylor PD, Faris TD, Herrmann TJ, et al. Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog. Surgery 1965;58:131-55
10. Starzl TE, Marchioro TL, Porter KA, Iwasaki Y, Cerilli GJ. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet 1967;124:301-18
11. Cordier G, Garnier H, Clot JP, Camplez P, Gorin JP, Clot Ph, et al. La greffe de foie orthotopique chez le porc. Mem Acad Chir (Paris) 1966;92:799-807
12. Peacock JH, Terblanche J. Orthotopic homotransplantation of the liver in the pig. In: Read AE, editor. The liver. London: Butterworth; 1967. p. 333
13. Calne RY, White HJO, Yoffa DE, Maginn RR, Binns RM, Samuel JR, et al. Observations of orthotopic liver transplantation in the pig. Br Med J 1967;2:478-80
14. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-4
15. Starzl TE. Rejection in unmodified animals. In: Experience in hepatic transplantation. Philadelphia: Saunders; 1969. p. 184-92
16. Kamada N, Brons G, Davies HS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980;29:429-31
17. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994;19:916-24
18. Corry RJ, Winn HJ, Russell PS. Primary vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973;6:343-50
19. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homo-transplantation of the human liver. Ann Surg 1968;168:392-415
20. Barnard CN. What we have learned about heart transplants. J Thorac Cardiovasc Surg 1968;56:457-68
21. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; 2:1366-9
22. Starzl TE. History of clinical transplantation. World J Surg 2000;24:759-82
23. Murray JE, Merrill JP, Dammin GJ, Dealy JB Jr, Walter CW, Brooke MS, et al. Study of transplantation immunity after total body irradiation: clinical and experimental investigation. Surgery 1960;48:272-84
24. Hamburger J, Vaysse J, Crosnier J, Auvert J, Lalanne CL, Hopper J Jr. Renal homotransplantation in man after radiation of the recipient. Am J Med 1962;32:854-71
25. Kuss R, Legrain M, Mathe G, Nedey R, Camey M. Homologous human kidney transplantation. Experience with six patients. Postgrad Med J 1962;38:528-31
26. Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. New Engl J Med 1963;268:1315-23
27. Starzl TE. Experience in renal transplantation. Philadelphia: W.B. Saunders Company; 1964. p. 1-383
28. Starzl TE, Porter KA, Iwasaki Y, Marchioro TL, Kashiwagi N. The use of antilymphocyte globulin in human renal homotransplantation. In: Wolstenholme GEW, O'Connor M, editors. Antilymphocytic serum. London: J and A Churchill Limited; 1967. p. 4-34
29. Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs; 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979;2:1033-6
30. Starzl TE, Weil R III, Iwatsuki S, Klintmalm G, Schroter GPJ, Koep LJ, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980;151:17-26
31. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramanan R, Jain A. FK 506 for human liver, kidney and pancreas transplantation. Lancet 1989;2:1000-4
32. Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, et al. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990;212:295-305
33. Starzl TE, Klintmalm GBG, Porter KA, Iwatsuki S, Schroter GPJ. Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med 1981;305:266-9
34. Todo S, Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, et al. Single center experience with primary orthotopic liver transplantation under FK506 immunosuppression. Ann Surg 1994;220:297-309
35. Mathe G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M. Haematopoietic chimera in man after allogenic (homologous) bone-marrow transplantation. Brit Med J 1963;2:1633-5
36. Bach FH. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968;2:1364-6
37. Thomas ED. Allogeneic marrow grafting: a story of man and dog. In: Terasaki PI, editor. History of transplantation: thirty-five recollections. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1991. p. 379-93
38. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, et al. Marrow transplantation from related donors other than HLA-Identical siblings. New Eng. J. Med. 1985;313:765-71
39. Stewart BL, Storer B, Storek J, Joachim Deeg H, Storb R, Hansen JA, et al Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004;104:3501-6
40. Barker CF, Billingham RE. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 1968;128:197-221
41. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic ignorance of vascularized organ transplants in the absence of secondary lymphoid tissue. Nature Med 2000;6:686-8
42. Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, Miyawaki S, et al. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med 1997;185:2157-70
43. Starzl TE. Late results and complications. In: Experience in hepatic transplantation. Philadelphia, PA: WB Saunders Company; 1969. p. 348-93
44. Starzl TE. Efforts to mitigate or prevent rejection. In: Experience in hepatic transplantation. Philadelphia: Saunders, 1969. p. 227-33
45. Doherty PC, Zinkernagel RM. A biological role for the major histocompatibility antigens. Lancet 1975;1(7922):1406-9
46. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997;18:14-7
47. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:1142-62
48. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990;63:1249-56
49. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-61
50. Wilson WEC, Kirkpatrick CH. Immunologic aspects of renal homotransplantations. In: Starzl TE, editor. Experience in renal transplantation. Philadelphia: W.B. Saunders Company; 1964. p. 239-61
51. Kirkpatrick CH, Wilson WEC, Talmage DW. Immunologic studies in human organ transplantation. I. Observations and characterization of suppressed cutaneous reactivity in uremia. J Exp Med 1964;119:727
52. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993;17: 1127-52
53. Kashiwagi N, Porter KA, Penn I, Brettschneider L, Starzl TE. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum 1969;20:374-6
54. Murase N, Demetris AJ, Matsuzaki T, Yagihasi A, Todo S, Fung J, et al. Long survival in rats after multivisceral versus isolated small bowel allotransplantation under FK 506. Surgery 1991;110:87-98
55. Iwaki Y, Starzl TE, Yagihashi A, Taniwaki S, Abu-Elmagd K, Tzakis A, et al. Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression. Lancet 1991;337:818-9
56. Nemlander A, Soots A, von Willebrand E, Husberg B, Hayry P. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity. J Exp Med 1982;156:1087-100
57. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel route for initiation of rejection. J Exp Med 1990;171:307-14
58. Demetris AJ, Qian S, Sun H, Fung JJ, Yagihashi A, Murase N, et al. Early events in liver allograft rejection: delineation of sites simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991;138:609-18
59. Starzl TE, Todo S, Tzakis A, Alessiani M, Casavilla A, Abu-Elmagd K, et al. The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991;172:335-44
60. Murase N, Demetris AJ, Woo J, Tanabe M, Furuya T, Todo S, et al. Graft versus host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506. Transplantation 1993;55:1-7
61. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-82
62. Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992;340:876-7
63. Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad S, Terasaki PI, et al. Chimerism after liver transplantation for type IV glycogen storage disease and Type I Gaucher's disease. N Engl J Med 1993;328:745-9
64. Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993;55:1272-7
65. Przepiorka D, Thomas ED, Durham DM, Fisher L. Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol 1991;95:201-6
66. Starzl TE, Demetris AJ. Transplantation milestones: viewed with one- and two-way paradigms of tolerance. JAMA 1995;273:876-9
67. Starzl TE, Zinkernagel R. Antigen localization and migration in immunity and tolerance. New Engl J Med 1998;339:1905-13
68. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945;102:400-1
69. Martinez C, Shapiro F, Good RA. Essential duration of parabiosis and development of tolerance to skin homografts in mice. Proc Soc Exp Biol Med 1960;104:256-9
70. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: Microchimerism. Immunol Today 1996;17:577-84
71. Starzl TE. The mystique of organ transplantation. J Am Coll Surg 2005;201:160-70
72. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci 2004;101(Suppl. 2):14607-14
73. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993;25:3337-44
74. Murase N, Demetris AJ, Woo J, Tanabe M, Furuya T, Todo S, et al Graft versus host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506. Transplantation 1993;55:1-7
75. Terakura M, Murase N, Demetris AJ, Ye Q, Thomson A, Starzl TE. Lymphoid/non-lymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation 1998;66:350-7
76. Sakamoto T, Ye Q, Lu L, Demetris AJ, Starzl TE, Murase N. Donor hematopoietic progenitor cells in non myeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation 1999;67:833-840
77. Lu L, Rudert WA, Qian S, McCaslin D, Fu F, Rao AS, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995;182:379-87
78. Ricordi C, Ildstad ST, Demetris AJ, Abou El-Ezz AY, Murase N, Starzl TE. Donor dendritic cells repopulaton in recipients after rat-to-mouse bone-marrow transplantation. Lancet 1992;339:1610-11
79. Zinkernagel RM, Moskophidis D, Kundig T, Oehen S, Pircher H, Hengartner H. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. Immunol Rev 1993;131:199-223
80. Zinkernagel RM, Hengartner H. T-cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994;15: 262-8
81. Zinkernagel RM. Immunology taught by viruses. Science 1996;271:173-8
82. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Reviews 1997;156:199-209
83. Sivasai KS, Alevy TY, Duffy BF, Brennan DC, Singer GG, Shenoy S, et al. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 1997;64:427-32
84. Inman B, Halloran B, Melk A, Ramassar V, Halloran PF. Microchimerism in sensitized renal patients. Transplantation 1999;67:1381-4
85. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Ann Rev Immunol 1983;1:143-73
86. Algire GH, Weaver JM, Prehn RT. Studies on tissue homotransplantation in mice using diffusion chamber methods. Ann New York Acad Sci 1957;64:1009
87. Kiyomoto T, Toyokawa H, Nakao A, Kaizu T, Okuda T, Demetris AJ, et al. The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation 2006;81:438-44
88. Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev: Immunol 2001;1:233-9
89. Bonilla WV, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006;116:156-62
90. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-12
91. Starzl TE, Penn I, Putnam CW, Groth CG, Halgrimson CG. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971;7:112-45
92. Barber WH, Mankin JA, Laskow DA, Dierhoi MH, Julian BA, Curtis JJ, et al. Long term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991;51:70-5
93. Fontes P, Rao A, Demetris AJ, Zeevi A, Trucco M, Carroll P, et al. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994;344:151-5
94. Tryphonopoulos P, Tzakis AG, Weppler D, Garcia-Morales R, Kato T, Madariaga JR, et al. The role of donor bone marrow infusions in withdrawal of Immunosuppression in adult liver allotransplantation. Am J Transplant 2005;5:608-13
95. Murase N, Starzl TE, Tanabe M, Fujisaki S, Miyazawa H, Ye Q, et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 1995;60:158-71
96. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-10
97. Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, Murase N, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (ThymoglobulinR). Am J Transplant 2005;5:1430-6
98. McCurry K, Iacano A, Zeevi A, Yousem S, Girnita A, Husain S, et al. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by post-transplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005;130:528-37
99. Shapiro R, Ellis D, Tan HP, Moritz ML, Basu A, Vats AN, et al. Antilymphoid antibody preconditioning with tacrolimus monotherapy for pediatric renal transplantation. J Pediatr 2006;148:813-8
100. Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005;200:505-15
101. Lilly JR, Giles G, Hurwitz R, Schroter G, Takagi H, Gray S, et al. Renal homotransplantation in pediatric patients. Pediatr 1971;47:548-57
102. Eghtesad B, Fung JJ, Demetris AJ, Murase N, Ness R, Bass DC, et al. Mechanism-based principles of immunosuppression for liver transplantation in HCV-infected patients. Liver Transplant 2005;11:1343-52
103. Starzl TE. Organ transplantation: a practical triumph and epistemologic collapse. Proc Am Philos Soc 2003;147:226-45
104. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003;76:120-9
105. Knechtle SJ, Pirsch JD, Fechner HJ Jr, Becker BN, Friedl A, Colvin RB, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003;3:722-30
106. Perico N, Amuchastegui S, Bontempelli M, Remuzzi G. The kidney triggers graft-versus-host disease in experimental combined transplantation of kidney and stem cell-enriched peripheral leukocytes. J Am Soc Nephrol 1996;7:2254-8
107. Ricordi C, Tzakis AG, Zeevi A, Rybka WB, Demetris AJ, Fontes PAC, et al. Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplantation 1994;3:187-92
108. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996;17(12):584-588
109. Wekerle T, Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation 1999;68:459-467
110. Bushell A, Pearson TC, Morris PJ, Wood KJ. Donor-recipient microchimerism and tolerance induction. Transplantation 1996;61:170-2